Skip to content

Medical emergency? What to do

Small suicidal behavior risk linked to drug therapy

3-RXPublished March 8, 20063 min read

Key points

  • During the early phase of antidepressant treatment of pediatric patients, there is a slight increased risk of suicidal thoughts and behavior, the results of several studies suggest.
  • Thomas Laughren and his colleagues in Rockville, Maryland, analyzed data from 24 studies ranging from 4 to 16 weeks in length that included 4,582 patients.
  • There were 209 suicide-related events but no completed suicides.
  • When considering 100 patients on drug therapy, we might expect one to three patients to have an increase in suicidal behavior -- beyond the risk that occurs with depression itself, Laughren noted.

During the early phase of antidepressant treatment of pediatric patients, there is a slight increased risk of suicidal thoughts and behavior, the results of several studies suggest.

However, the US Food and Drug Administration research team that conducted the study review does not discourage the use of antidepressant drugs for children. Instead, they advise "close monitoring of patients as a way of managing the risk of suicidality," according to their report in the Archives of General Psychiatry for March.

Dr. Thomas Laughren and his colleagues in Rockville, Maryland, analyzed data from 24 studies ranging from 4 to 16 weeks in length that included 4,582 patients. The drugs tested were Prozac (fluoxetine), Zoloft (sertraline), Paxil (paroxetine), Luvox (fluvoxamine), Celexa (citalopram), Wellbutrin (bupropion), Effexor (venlafaxine), Serzone (nefazodone) and Remeron (mirtazapine).

The children's diagnoses included major depression, obsessive-compulsive disorder and generalized anxiety disorder.

There were 209 suicide-related events but no completed suicides. Eighty-nine episodes were attributed to suicidal behavior or thoughts, and 120 were associated with possible suicidal behavior or thoughts.

The overall risk for suicidal behavior that accompanied all of the drugs and diagnoses was increased by 95 percent. The increased risk associated with selective serotonin reuptake inhibitors -- Prozac, Zoloft, Paxil, Luvox and Celexa -- in depression trials was 66 percent. The authors note that risk estimates often varied between trials of the same drug.

When considering 100 patients on drug therapy, we might expect one to three patients to have an increase in suicidal behavior -- beyond the risk that occurs with depression itself, Laughren noted.

The investigators suggest that the apparent increased risk of drug-induced suicidal behavior may be related to a greater likelihood of the patients to report the symptoms rather an actual increase risk. They point out that several of the drugs reduce social anxiety and increase communication with others.

This theory is supported by the decline in adolescent suicide in recent years, Laughren and his team point out. For example, there has been a documented 31 percent reduction in suicide risk among males aged 15 to 19 years between 1992 and 2002.

Moreover, the FDA has not banned antidepressant drugs for pediatric use, opting instead for new labeling warning of the risk and recommending that physicians balance the risk with the need, because "depression and psychiatric disorders in pediatric patients can have significant consequences if not appropriately treated."

In a related editorial, Dr. Ross J. Baldessarini from McLean Hospital in Belmont, Massachusetts, and colleagues suggest that "potential adverse effects of antidepressant treatment, such as worsening insomnia, agitation, restlessness, irritability, and anger, or their adverse impact on unrecognized bipolar disorders contributes to increased risk of suicidal acts in occasional patients."

They suggest that discontinuing the antidepressant medication or adding agents to reduce agitation and aggression, such as antipsychotic or antimanic drugs, may reverse suicidal thoughts or behavior.

SOURCE: Archives of General Psychiatry, March 2006.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.